News News Archive Email A Friend April 22, 2024 California Division of Workers’ Compensation Posts Updated Time of Hire Notice April 22, 2024 Sullivan on Comp Launches ChatSOC. It's an Innovative Chatbot for California Workers' Compensation Professionals Integrated with an Authoritative Legal Treatise April 19, 2024 Workers Compensation Bill 2024: One percent of employee’s salary to contribute to workers’ compensation fund in Kenya. April 15, 2024 Colorado Worker Shows Head Injury Happened as a Consequence of a Knock on the Head at Work
| | California Division of Workers' Compensation Issues Notice of Public Hearing for Drug Formulary Regulations By California Division of Workers' Compensation - March 17, 2017
The Department of Industrial Relations’ Division of Workers’ Compensation (DWC) has issued a notice of public hearing on May 1 for the Medical Treatment Utilization Schedule (MTUS) Drug Formulary regulations, which includes a list of preferred drugs that can be dispensed without the need for prospective utilization review. The proposed rulemaking implements Assembly Bill 1124 (Statutes 2015, Chapter 525), which mandated the adoption of an evidence-based workers’ compensation drug formulary into the MTUS by July 1, 2017.
“We must ensure that California’s injured workers are prescribed the right medications for their conditions without frictional system delays,” said George Parisotto, DWC Acting Administrative Director. DWC is a division of the Department of Industrial Relations (DIR).
The May 1 public hearing on the proposed regulations has been scheduled at 10 a.m. in the auditorium of the Elihu Harris Building, 1515 Clay Street, Oakland, CA 94612. Members of the public may also submit written comments on the regulations until 5 p.m. that day.
The MTUS Drug Formulary is based on, and consistent with, medical treatment guidelines created by the American College of Occupational and Environmental Medicine (ACOEM), which are published by Reed Group, Ltd. The preferred drug list was compiled by DWC, with assistance from ACOEM, and takes into consideration medications frequently prescribed for occupational injuries and the evidence-based drug recommendations in the guidelines.
“The formulary, designed to work in tandem with our medical treatment utilization guidelines, will incorporate the evidence-based standards of care that best meet the needs of California’s injured workers,” said Christine Baker, Director of DIR.
The proposed formulary regulations are to be adopted at section 9792.27.1, et seq. of Title 8 of the California Code of Regulations. DWC will consider all public comments, and may modify the proposed regulations for consideration during an additional 15-day public comment period.
The notice of rulemaking, text of the regulations, and the initial statement of reasons can be found on the DWC rulemaking web page.
More information about the rulemaking process can be found on the Office of Administrative Law’s (OAL) website.
#
The California Department of Industrial Relations, Division of Workers' Compensation, www.dir.ca.gov
lonce@adjustercom.com, Lonce LaMon, journalist, adjustercom
|